BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15647846)

  • 21. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemopoietic chimerism following stem cell transplantation.
    McCann SR; Crampe M; Molloy K; Lawler M
    Transfus Apher Sci; 2005 Feb; 32(1):55-61. PubMed ID: 15737874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation.
    Mangioni S; Balduzzi A; Rivolta A; Rovelli A; Nesi F; Rossi V; Busca A; Uderzo C; Miniero R; Biondi A
    Bone Marrow Transplant; 1997 Dec; 20(11):969-73. PubMed ID: 9422477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex chromosome changes after sex-mismatched allogeneic bone marrow transplantation can mislead the chimerism analysis.
    Alpár D; Nagy G; Hohoff C; Kajtár B; Bartyik K; Hermesz J; Jáksó P; Andrikovics H; Kereskai L; Pajor L
    Pediatr Blood Cancer; 2010 Dec; 55(6):1239-42. PubMed ID: 20979181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.
    Bacher U; Badbaran A; Fehse B; Zabelina T; Zander AR; Kröger N
    Exp Hematol; 2009 Jan; 37(1):135-42. PubMed ID: 19100523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect.
    Díez-Martín JL; Gómez-Pineda A; Serrano D; Carrión R; Balsalobre P; Buño I
    Bone Marrow Transplant; 2004 May; 33(10):1037-41. PubMed ID: 15064692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [DNA polymorphism, allogenic bone marrow transplantation and peripheral cell chimerism].
    Brdicka R; Sieglová Z; Honzátková L; Dvoráková R; Hrabánek J; Kobylka P; Vítek A; Sedlácek P; Starý J
    Cas Lek Cesk; 1998 Feb; 137(4):110-9. PubMed ID: 9531733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FISH detection of chimerism in pediatric hematopoietic stem cell transplantation.
    Aydin F; Oguz F; Onal AE; Bilgen H; Oguz R; Anak S; Carin M; Gedikoglu G
    Int J Lab Hematol; 2007 Jun; 29(3):208-14. PubMed ID: 17474899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens.
    Gerritsen WR; Jagiello CA; Bourhis JH
    Bone Marrow Transplant; 1994 Apr; 13(4):441-7. PubMed ID: 8019469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed chimerism after bone marrow transplantation for thalassemia major.
    Li CK; Chik KW; Tsang KS; Pong H; Shing MM; Yuen PM
    Haematologica; 2002 Jul; 87(7):781-2. PubMed ID: 12091135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
    Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
    Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
    Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
    Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.
    Huisman C; de Weger RA; de Vries L; Tilanus MG; Verdonck LF
    Bone Marrow Transplant; 2007 Mar; 39(5):285-91. PubMed ID: 17262061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells.
    McGregor DK; Keever-Taylor CA; Bredeson C; Schur B; Vesole DH; Logan B; Chang CC
    Bone Marrow Transplant; 2005 Jun; 35(11):1049-54. PubMed ID: 15821762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection of relapse in patients with myelodysplastic syndrome after allo-SCT.
    Tobiasson M; Olsson R; Hellström-Lindberg E; Mattsson J
    Bone Marrow Transplant; 2011 May; 46(5):719-26. PubMed ID: 20697367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
    Cesaro S; Pillon M; Visintin G; Putti MC; Gazzola MV; D'Amore E; Scarzello G; Zanesco L; Messina C; Rosolen A
    Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization.
    Nagler A; Ilan Y; Amiel A; Eid A; Tur-Kaspa R
    Transplantation; 1994 May; 57(10):1458-61. PubMed ID: 8197608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms for the size of heterochromatic regions allow sex-independent quantification of post-BMT chimerism targeting metaphase and interphase cells.
    Buño I; Díez-Martín JL; López-Fernández C; Fernández JL; Gosálvez J
    Haematologica; 1999 Feb; 84(2):138-41. PubMed ID: 10091412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.